Levetiracetam Pensa (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. By stabilizing synaptic activity, it reduces neuronal hyperexcitability and the likelihood of seizure generation without significant interaction with major receptor systems.

The appropriate dose of Levetiracetam Pensa is individualized and set by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Levetiracetam is classified as pregnancy category unknown. Because safety data are limited, women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Levetiracetam Pensa. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with older antiepileptics such as carbamazepine or valproate, levetiracetam has a simpler pharmacokinetic profile, fewer drug‑enzyme interactions, and a generally favorable tolerability profile. However, individual response varies, and clinicians choose therapy based on seizure type, comorbidities and patient‑specific factors.

Levetiracetam Pensa should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Levetiracetam Pensa is supplied as an oral tablet. It should be swallowed whole with a glass of water, with or without food, as directed by the prescriber. The tablet should not be crushed, chewed, or divided unless specifically advised.

Patients should be alert for severe allergic reactions such as anaphylaxis, skin conditions like Stevens‑Johnson syndrome, and any new or worsening mood changes, including depression or suicidal thoughts. Immediate medical attention is required if any of these serious events occur.

Levetiracetam Pensa is contraindicated in individuals with a known hypersensitivity to levetiracetam or any of its excipients. Patients with severe renal impairment must receive dose adjustments; otherwise, use should be avoided unless a specialist determines that benefits outweigh risks.